国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Xenopus laevis Coiled-coil and C2 domain-containing protein 1B (cc2d1b), partial CSB-YP747477XBE
CSB-EP747477XBE
CSB-BP747477XBE
CSB-MP747477XBE
CSB-EP747477XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Kinesin-like protein KIF18B (Kif18b), partial CSB-YP747478MO
CSB-EP747478MO
CSB-BP747478MO
CSB-MP747478MO
CSB-EP747478MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Sodium-dependent phosphate transporter 1-B (slc20a1b), partial CSB-YP747479DIL
CSB-EP747479DIL
CSB-BP747479DIL
CSB-MP747479DIL
CSB-EP747479DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Eukaryotic translation initiation factor 3 subunit C (eif3c), partial CSB-YP747480DIL
CSB-EP747480DIL
CSB-BP747480DIL
CSB-MP747480DIL
CSB-EP747480DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse BEN domain-containing protein 6 (Bend6) CSB-YP747481MO
CSB-EP747481MO
CSB-BP747481MO
CSB-MP747481MO
CSB-EP747481MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Apoptosis-related protein 3 (41367), partial CSB-YP747482MO
CSB-EP747482MO
CSB-BP747482MO
CSB-MP747482MO
CSB-EP747482MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Uncharacterized protein C12orf34 homolog CSB-YP747483MO
CSB-EP747483MO
CSB-BP747483MO
CSB-MP747483MO
CSB-EP747483MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio UPF0668 protein C10orf76 homolog (zgc:63733), partial CSB-YP747484DIL1
CSB-EP747484DIL1
CSB-BP747484DIL1
CSB-MP747484DIL1
CSB-EP747484DIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio TRAF3-interacting protein 1 (traf3ip1), partial CSB-YP747485DIL
CSB-EP747485DIL
CSB-BP747485DIL
CSB-MP747485DIL
CSB-EP747485DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Glycine amidinotransferase, mitochondrial (gatm), partial CSB-YP747486DIL
CSB-EP747486DIL
CSB-BP747486DIL
CSB-MP747486DIL
CSB-EP747486DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Charged multivesicular body protein 1a (chmp1a) CSB-YP747487DIL
CSB-EP747487DIL
CSB-BP747487DIL
CSB-MP747487DIL
CSB-EP747487DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Coiled-coil domain-containing protein 57 (Ccdc57), partial CSB-YP747488MO
CSB-EP747488MO
CSB-BP747488MO
CSB-MP747488MO
CSB-EP747488MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Putative RNA-binding protein 15B (Rbm15b), partial CSB-YP747489MO
CSB-EP747489MO
CSB-BP747489MO
CSB-MP747489MO
CSB-EP747489MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Aspartate--tRNA ligase, mitochondrial (DARS2) CSB-YP747490HU
CSB-EP747490HU
CSB-BP747490HU
CSB-MP747490HU
CSB-EP747490HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Mediator of RNA polymerase II transcription subunit 24 (med24), partial CSB-YP747491XBE
CSB-EP747491XBE
CSB-BP747491XBE
CSB-MP747491XBE
CSB-EP747491XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Tetratricopeptide repeat protein 33 (TTC33) CSB-YP747492HU
CSB-EP747492HU
CSB-BP747492HU
CSB-MP747492HU
CSB-EP747492HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Potassium voltage-gated channel subfamily V member 1 (KCNV1), partial CSB-YP747493HU1
CSB-EP747493HU1
CSB-BP747493HU1
CSB-MP747493HU1
CSB-EP747493HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Uncharacterized protein C17orf80 homolog (D11Wsu47e), partial CSB-YP747494MO
CSB-EP747494MO
CSB-BP747494MO
CSB-MP747494MO
CSB-EP747494MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Poly (A) RNA polymerase GLD2 (PAPD4) CSB-YP747495HU
CSB-EP747495HU
CSB-BP747495HU
CSB-MP747495HU
CSB-EP747495HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse DALR anticodon-binding domain-containing protein 3 (Dalrd3) CSB-YP747496MO
CSB-EP747496MO
CSB-BP747496MO
CSB-MP747496MO
CSB-EP747496MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>